Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v14-FR
Language French French
Date Updated 2021-10-19 2021-10-19
Drug Identification Number 01911481 01911481
Brand name INHIBACE INHIBACE
Common or Proper name INHIBACE 5 MG 100 INHIBACE 5 MG 100
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients CILAZAPRIL CILAZAPRIL
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-05-08 2020-05-08
Estimated end date 2021-09-30 2021-09-30
Actual end date 2021-09-24 2021-09-24
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments